Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 19, 1998

View Archived Issues

Cell Therapeutics: Q3 1998 highlights

Vical: Q3 1998 highlights

Neurocrine Biosciences: Q3 1998 highlights

Contrast sonography with Echovist is safe and effective for assessing tubal patency

New LYMErix study results point to faster immunization

New compound described for the treatment of pregnancy-induced hypertension

Phytoanalgesic agent WS-1531 shows limited efficacy, good safety in treating back pain

Pexiganan acetate: a potent and broad-spectrum antibiotic with few resistance problems

Organogenesis completes patient enrollment in Apligraf diabetic foot ulcer trial

U.S. patent protects methods of angiogenesis inhibition using Xoma's BPI products

Endothelin antagonists a focus of R&D at Merck KGaA

Three major studies support antiglaucoma efficacy of Cosopt

Anti-H. pylori cephems in development at Takeda

Mercian presents HIV protease inhibitors produced by fungus

Wide series of 5-HT antagonists from Eisai useful as antispastic agents, central muscle relaxants

Agents for nephritis in the Tsumura pipeline

Viagra now on the shelves in U.K. pharmacies

First potent, orally active LHRH antagonist discovered by Takeda

p38 kinase inhibitor RWJ-68354: a promising clinical candidate for inflammatory conditions

Major component of antibiotic complex expected to be useful as an anti-MRSA agent

Safe and effective treatment of acute CHF with nesiritide

ACR attendants learn more about the efficacy and safety of Enbrel in patients with RA, JRA

First oral medication for periodontitis now available in U.S. pharmacies

Increased dose strengths of Raxar now available in single-therapy box

Bayer cleared to acquire Chiron Diagnostics

MPIF advances to phase II trials in cancer patients

FDA Advisory Committee recommends approval of Ligand's Panretin Gel

Inhibitor of selectin-dependent cell adhesion (BMS-184000) evaluated in models of inflammation

Ozagrel hydrochloride effectively prevents development of preeclampsia in pregnant women

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...